A measurement study of blood components upon consumption of the test food

A measurement study of blood components upon consumption of the test food: a randomized, double-blind, crossover comparison trial - A measurement study of blood components upon consumption of the test food

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051271

Enrollment

Registered

2023-06-06

Start date

2023-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

&lt

Duration&gt

Single ingestion (two times) &lt

Test food&gt

Period I: Capsule containing Haematococcus algal extract (capsule form), sports drink (liquid form) Period II: Emulsified astaxanthin formulation (liquid form), placebo capsule (capsule form) &lt

Prescribed food&gt

Jelly drink &lt

Administration&gt

After the measurements before consumption of the test food, take in the order, the capsule form and liquid form test foods, and then the prescribed food (jelly drink). Take the test foods and the pres

Period I: Emulsified astaxanthin formulation (liquid form), placebo capsule (capsule form) Period II: Capsule containing Haematococcus algal extract (capsule form), sports drink (liquid form) &lt

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Adults 4. Healthy subjects

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

Measure	Time frame
The change of concentration of astaxanthin compounds in the blood	—

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026